3q29 microduplication syndrome

3q29 microduplication syndrome (also known as chromosome 3q29 duplication syndrome or trisomy 3q29) is a rare chromosomal disorder caused by a duplication of genetic material on the long arm of chromosome 3 at the 3q29 region, typically spanning approximately 1.6 megabases. This copy number gain results in three copies of the genes in this region instead of the usual two. The condition is classified under ICD-10 code Q92.3 (minor partial trisomy). The clinical presentation of 3q29 microduplication syndrome is highly variable, even among affected members of the same family. Some individuals may have mild or no apparent symptoms, while others present with developmental delay, intellectual disability (often mild to moderate), speech and language delays, and learning difficulties. Additional features may include microcephaly (small head size), ocular abnormalities, heart defects, and dysmorphic facial features. Behavioral and psychiatric manifestations, including features of autism spectrum disorder and attention deficit hyperactivity disorder, have also been reported in some individuals. Musculoskeletal and growth abnormalities may occasionally be observed. There is currently no specific cure or targeted therapy for 3q29 microduplication syndrome. Management is supportive and symptom-based, involving early intervention programs, speech therapy, occupational therapy, physical therapy, and special educational support as needed. Cardiac, ophthalmologic, and developmental evaluations are recommended. Genetic counseling is important for affected individuals and their families, particularly because the duplication may be inherited from a mildly affected or apparently unaffected parent.

Common questions about 3q29 microduplication syndrome